No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
National Lab Reporter
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
LDT Appeal: Looking at the Legal Nuances Behind Potential FDA Actions Following Court Decision
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Debate Continues Over FDA Regulation of LDTs
...
Already a member? Log in here
New Webinar
...
Already a member? Log in here
Colon Cancer Screening Test Gets FDA Approval, Proposed Medicare Coverage
...
Already a member? Log in here
FDA Plans to Regulate Lab-Developed Tests Could Increase Time and Cost of Development
In its July 31 notice to Congress, the agency says it would phase in oversight requirements over nine years.
Labs Finalizing Policies and Procedures Under Patient Access Rule
...
Already a member? Log in here
FDA Official Defends Plan to Issue Guidance for LDTs
...
Already a member? Log in here
Texas Lab Must Repay Government $10.6 Million for Illegal Travel Expenses
...
Already a member? Log in here
Medicare Payments to Hospital Outpatient Labs Showing Huge Shift
...
Already a member? Log in here